Docking and scoring with ICM: the benchmarking results and strategies for improvement

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Computer-Aided Molecular Design

• Publication date

  2012-05-09

• Fields of study

  Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.1007/s10822-012-9547-0PMID 22569591PMCID PMC3398187
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pocketome: an encyclopedia of small-molecule binding sites in 4D

  2011cited by this paper
• Triazole-linked reduced amide isosteres: an approach for the fragment-based drug discovery of anti-Alzheimer's BACE1 inhibitors.

  2011cited by this paper
• Status of GPCR modeling and docking as reflected by community-wide GPCR Dock 2010 assessment.

  2011cited by this paper
• FRED Pose Prediction and Virtual Screening Accuracy

  2011cited by this paper
• In Search of Allosteric Modulators of α7-nAChR by Solvent Density Guided Virtual Screening

  2011cited by this paper
• Chromene-3-carboxamide derivatives discovered from virtual screening as potent inhibitors of the tumour maker, AKR1B10.

  2010cited by this paper
• pKa based protonation states and microspecies for protein–ligand docking

  2010cited by this paper
• Tautomer Preference in PDB Complexes and its Impact on Structure-Based Drug Discovery

  2010cited by this paper
• Relevance of Weak Hydrogen Bonds in the Conformation of Organic Compounds and Bioconjugates: Evidence from Recent Experimental Data and High-Level ab initio MO Calculations

  2010cited by this paper
• n?p* interactions in proteins

  2010cited by this paper
• Molecular recognition and drug-lead identification: what can molecular simulations tell us?

  2010cited by this paper
• Improved docking, screening and selectivity prediction for small molecule nuclear receptor modulators using conformational ensembles

  2010cited by this paper
• Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor.

  2010cited by this paper
• Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists.

  2010cited by this paper
• The RCSB Protein Data Bank: redesigned web site and web services

  2010cited by this paper
• The pthaladyns: GTP competitive inhibitors of dynamin I and II GTPase derived from virtual screening.

  2010cited by this paper
• n→π* Interactions in Proteins

  2010cited by this paper
• SimiCon: a web tool for protein-ligand model comparison through calculation of equivalent atomic contacts

  2010cited by this paper
• Relevance of weak hydrogen bonds in the conformation of organic compounds and bioconjugates: evidence from recent experimental data and high-level ab initio MO calculations.

  2010cited by this paper
• Ligand-guided optimization of CXCR4 homology models for virtual screening using a multiple chemotype approach

  2010cited by this paper
• In Silico Screening for PTPN22 Inhibitors: Active Hits from an Inactive Phosphatase Conformation

  2009cited by this paper
• Four-dimensional docking: a fast and accurate account of discrete receptor flexibility in ligand docking.

  2009cited by this paper
• Empirical Scoring Functions for Advanced Protein-Ligand Docking with PLANTS

  2009cited by this paper
• Theoretical Biology and Medical Modelling Open Access Binding Site of Abc Transporter Homology Models Confirmed by Abcb1 Crystal Structure

  2009cited by this paper
• Structure-based drug design strategies in medicinal chemistry.

  2009cited by this paper
• RosettaLigand docking with full ligand and receptor flexibility.

  2009cited by this paper
• A novel small-molecule inhibitor of the avian influenza H5N1 virus determined through computational screening against the neuraminidase.

  2009cited by this paper
• Discovery of potent thermolysin inhibitors using structure based virtual screening and binding assays.

  2009cited by this paper
• Optimization of CAMD techniques 3. Virtual screening enrichment studies: a help or hindrance in tool selection?

  2008influential reference
• Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to go

  2008cited by this paper
• Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening.

  2008cited by this paper
• Type-II kinase inhibitor docking, screening, and profiling using modified structures of active kinase states.

  2008cited by this paper
• Ligand-Protein Docking with Water Molecules

  2008cited by this paper
• Diverse, high-quality test set for the validation of protein-ligand docking performance.

  2007cited by this paper
• Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugs

  2007cited by this paper
• Evaluating Virtual Screening Methods: Good and Bad Metrics for the "Early Recognition" Problem

  2007cited by this paper
• Structure-based drug design: docking and scoring.

  2007cited by this paper
• From selective substrate analogue factor Xa inhibitors to dual inhibitors of thrombin and factor Xa. Part 3.

  2007cited by this paper
• Benchmarking sets for molecular docking.

  2006cited by this paper
• Role of binding entropy in the refinement of protein–ligand docking predictions: Analysis based on the use of 11 scoring functions

  2006cited by this paper
• Virtual screening against metalloenzymes for inhibitors and substrates.

  2005cited by this paper
• Prediction of binding modes for ligands in the cytochromes P450 and other heme‐containing proteins

  2005cited by this paper
• Quantification of cation-pi interactions in protein-ligand complexes: crystal-structure analysis of Factor Xa bound to a quaternary ammonium ion ligand.

  2005cited by this paper
• Docking and scoring of metallo-beta-lactamases inhibitors.

  2004cited by this paper
• Docking and scoring of metallo-β-lactamases inhibitors

  2004cited by this paper
• Discovery of diverse thyroid hormone receptor antagonists by high-throughput docking

  2003cited by this paper
• Molecular model of the neural dopamine transporter

  2003cited by this paper
• Molecular Mechanism of Citalopram and Cocaine Interactions with Neurotransmitter Transporters

  2003cited by this paper
• Nuclear hormone receptor targeted virtual screening.

  2003cited by this paper
• Structural model of nicotinic acetylcholine receptor isotypes bound to acetylcholine and nicotine

  2002cited by this paper
• Structural basis for inhibition promiscuity of dual specific thrombin and factor Xa blood coagulation inhibitors.

  2001cited by this paper
• In silico discovery of novel Retinoic Acid Receptor agonist structures

  2001cited by this paper
• Inclusion of Solvation in Ligand Binding Free Energy Calculations Using the Generalized-Born Model

  1999cited by this paper
• Prediction of the binding energy for small molecules, peptides and proteins

  1999cited by this paper
• Flexible protein–ligand docking by global energy optimization in internal coordinates

  1997cited by this paper
• Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94

  1996cited by this paper
• ICM—A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation

  1994cited by this paper

• Molecular docking in histological biomarker discovery and disease modeling: techniques, validation, and translational perspectives

  2026cites this paper
• Multitarget Antioxidant and Anticancer Potential of Euphorbia greenwayi Essential Oil: Phytochemical Profiling and Molecular Insights

  2026cites this paper
• Discovery of an autoinhibited conformation in mesotrypsin reveals a strategy for selective serine protease inhibition

  2025cites this paper
• KEAP1 C151 active site catalysis drives electrophilic signaling to upregulate cytoprotective enzyme expression

  2025cites this paper
• Arabidopsis thaliana nicotinate mononucleotide adenylyltransferase: unveiling the molecular determinants and evolutionary origin of nicotinic acid mononucleotide recognition.

  2025cites this paper
• Synthesis, cytotoxicity, apoptosis-inducing activity and molecular docking studies of novel isatin–podophyllotoxin hybrids

  2025cites this paper
• Role of structure-based drug design (SBDD) in the repurposing and discovery of anti-viral leads against Monkeypox virus disease

  2025cites this paper
• Exploration of Fluorinated Pyrazolidine‐3,5‐Diones for Positron Emission Tomography Imaging of the P2Y12 Receptor in the Central Nervous System

  2025cites this paper
• Design and synthesis of Cereblon-based PROTAC as novel potent degraders of α/β-tubulin

  2025influential citation
• Novel GPU Engines for Virtual Screening of Giga-Sized Libraries Identify Inhibitors of Challenging Targets

  2025cites this paper
• Comparative Assessment of the Utility of Co-Folding and Docking for Small-Molecule Drug Design

  2025cites this paper
• Feed additives for methane mitigation: Recommendations for identification and selection of bioactive compounds to develop antimethanogenic feed additives.

  2025cites this paper
• Molecular basis of the activity of a photoswitchable histone deacetylase inhibitor

  2025cites this paper
• Virtual screening of FDA-approved drugs identifies amlodipine as a novel anti-Gyrodactylus kobayashii agent with therapeutic potential in aquaculture.

  2025cites this paper
• A novel chemoreactive calcilytic for the potential treatment of autosomal dominant hypocalcemia

  2025cites this paper
• Evaluating Molecular Docking Programs for RNA-Targeted Ligand Screening: Influence of Binding Modes and Ligand Types

  2025cites this paper
• The Six Ds of Exponentials and drug discovery: A path toward reversing Eroom's law.

  2025cites this paper
• Computational Repurposing of Approved Drugs: Exploring New Therapeutic Avenues for Liver Disorders

  2025influential citation
• Deep lead optimization enveloped in protein pocket and its application in designing potent and selective ligands targeting LTK protein

  2025cites this paper
• Deciphering the language of mingling lipids and proteins

  2025cites this paper
• Navigating structure-based drug discovery with emerging innovations in physics- and knowledge-based approaches

  2025cites this paper
• AI meets physics in computational structure-based drug discovery for GPCRs

  2025cites this paper
• Unveiling Dynamic Hotspots in Protein–Ligand Binding: Accelerating Target and Drug Discovery Approaches

  2025cites this paper
• Generating 3D small binding molecules using shape-conditioned diffusion models with guidance

  2025influential citation
• Next-Generation Analogues of AC265347 as Positive Allosteric Modulators of the Calcium-Sensing Receptor: Pharmacological Investigation of Structural Modifications at the Stereogenic Centre

  2025cites this paper
• Activity of STAMP inhibitors in ABL2 rearranged acute lymphoblastic leukemia is dependent on the Abl2 SH3 domain

  2025cites this paper
• Synthesis, Molecular Docking Analysis, and In Vitro Cytotoxic Evaluation of New Fluorinated γ‐Butyrolactone‐Aza‐Anthraquinone Compounds

  2025cites this paper
• Rules of engagement: determinants of chemokine receptor activation and selectivity by CCL27 and CCL28

  2025cites this paper
• Unlocking the therapeutic potential of unexplored phytocompounds as hepatoprotective agents through integration of network pharmacology and in-silico analysis

  2025influential citation
• Design, Synthesis, Computational Modeling and Biological Evaluation of Novel N‐(7H‐Pyrrolo[2,3‐d]pyrimidin‐4‐yl)cinnamamides as Potential Covalent Inhibitors for Oncology

  2025cites this paper
• Novel pyrido[2,3-b][1,4]oxazine-based EGFR-TK inhibitors: rational design and synthesis of potent and selective agents targeting resistance mutations in non-small cell lung cancer.

  2025cites this paper
• Developing novel Lin28 inhibitors by computer aided drug design

  2025cites this paper
• NAMPT and NNMT released via extracellular vesicles and as soluble mediators are distinguished traits of BRAF inhibitor resistance of melanoma cells impacting on the tumor microenvironment

  2025influential citation
• Potent β-lactam-based tyrosyl-DNA phosphodiesterase 1 inhibitors identified by a virtual screen

  2025cites this paper
• Enhancing the Reliability of Integrated Consensus Strategies to Boost Docking‐Based Screening Campaigns Using Publicly Available Docking Programs

  2025cites this paper
• Preparation, molecular docking, and anticaking determination of Pueraria lobata oligopeptide-silica protein corona complexes

  2024cites this paper
• Identifying Allosteric Small-Molecule Binding Sites of Inactive NS2B-NS3 Proteases of Pathogenic Flaviviridae

  2024cites this paper
• Noncanonical roles of chemokine regions in CCR9 activation revealed by structural modeling and mutational mapping

  2024cites this paper
• Structure-Based identification of a potent KDM7A inhibitor exerts anticancer activity through transcriptionally reducing MKRN1 in taxol- resistant and -sensitive triple-negative breast cancer cells.

  2024cites this paper
• Structure-based pose prediction: Non-cognate docking extended to macrocyclic ligands

  2024cites this paper
• A novel peptide‐based tau aggregation inhibitor as a potential therapeutic for Alzheimer's disease and other tauopathies

  2024cites this paper
• Recognition and remodeling of endosomal zones by sorting nexins.

  2024cites this paper
• Design and evaluation of nanoscale materials with programmed responsivity towards epigenetic enzymes.

  2024cites this paper
• Periplasmic binding proteins Bug69 and Bug27 from Bordetella pertussis are in vitro high‐affinity quinolinate binders with a potential role in NAD biosynthesis

  2024cites this paper
• A high-affinity, cis-on photoswitchable beta blocker to optically control β2-adrenergic receptors in vitro and in vivo.

  2024cites this paper
• In silico docking and molecular dynamics for the discovery of inhibitors of enteric methane production in ruminants — A review

  2024cites this paper
• Software and Databases for Protein-Protein Docking.

  2024cites this paper
• Cimicifugoside H-2 as an Inhibitor of IKK1/Alpha: A Molecular Docking and Dynamic Simulation Study

  2024cites this paper
• iBio-GATS—A Semi-Automated Workflow for Structural Modelling of Insect Odorant Receptors

  2024cites this paper
• Dissecting the Interaction Fingerprints and Binding Affinity of BYL719 Analogs Targeting PI3Kα.

  2024cites this paper
• ABC transporter inhibition by beauvericin partially overcomes drug resistance in Leishmania tropica

  2024influential citation
• Synthesis, Biological, and Computational Evaluations of Conformationally Restricted NAD-Mimics as Discriminant Inhibitors of Human NMN-Adenylyltransferase Isozymes

  2024cites this paper
• A New Highly Specific and Soluble Protease for Precise Removal of N‑Terminal Purification Tags

  2024cites this paper
• Synthesis, molecular docking analysis and in vitro evaluation of new heterocyclic hybrids of 4-aza-podophyllotoxin as potent cytotoxic agents

  2024cites this paper
• In situ cell-surface conformation of the TCR-CD3 signaling complex

  2024cites this paper
• Docking and other computing tools in drug design against SARS-CoV-2

  2024cites this paper
• Molecular insights into disease-associated glutamate transporter (EAAT1 / SLC1A3) variants using in silico and in vitro approaches

  2023cites this paper
• Redocking the PDB

  2023cites this paper
• PROTACable is an Integrative Computational Pipeline of 3-D Modeling and Deep Learning to Automate the De Novo Design of PROTACs

  2023cites this paper
• The oxidation of steroid derivatives by the CYP125A6 and CYP125A7 enzymes from Mycobacterium marinum.

  2023influential citation
• Integrated workflow for the identification of new GABAAR positive allosteric modulators based on the in silico screening with further in vitro validation. Case study using Enamine's stock chemical space

  2023cites this paper
• In Silico Characterization of the Novel SDR42E1 as a Potential Vitamin D Modulator.

  2023influential citation
• Development and Assessment of 1,5–Diarylpyrazole/Oxime Hybrids Targeting EGFR and JNK–2 as Antiproliferative Agents: A Comprehensive Study through Synthesis, Molecular Docking, and Evaluation

  2023cites this paper
• Improvement of binding pose prediction of the MR1 covalent ligands by inclusion of simple pharmacophore constraints and structural waters in the docking process

  2023cites this paper
• A generic binding pocket for small molecule I Ks activators at the extracellular inter-subunit 1 interface of KCNQ1 and KCNE1 channel complexes 2

  2023influential citation
• Therapeutic Switching of Rafoxanide: a New Approach To Fighting Drug-Resistant Bacteria and Fungi

  2023cites this paper
• Exploring Photoswitchable Binding Interactions with Small‐Molecule‐ and Peptide‐Based Inhibitors of Trypsin

  2023cites this paper
• Identification and characterisation of MdUGT78T2 as a galactosyltransferase with dual activity on flavonol and anthocyanidin substrates in red-skinned apple fruit (Malus domestica L.).

  2023cites this paper
• A computational framework for identifying chemical compounds to bind Apolipoprotein E4 for Alzheimer’s disease intervention

  2023cites this paper
• Theoretical modelling and molecular docking simulation evaluating 3-aryl-5-(alkyl-thio)-1 H-1,2,4-triazoles derivatives as potent anti-tubercular agents against MTB CYP121 receptor

  2023cites this paper
• Computer-aided drug design in seeking viral capsid modulators.

  2023cites this paper
• Reinventing Therapeutic Proteins: Mining a Treasure of New Therapies

  2023cites this paper
• A generic binding pocket for small molecule IKs activators at the extracellular inter-subunit interface of KCNQ1 and KCNE1 channel complexes

  2023cites this paper
• Development of Activity Rules and Chemical Fragment Design for In Silico Discovery of AChE and BACE1 Dual Inhibitors against Alzheimer’s Disease

  2023cites this paper
• Molecular determinants of antagonist interactions with chemokine receptors CCR2 and CCR5

  2023influential citation
• Lessons Learnt from COVID-19: Computational Strategies for Facing Present and Future Pandemics

  2023cites this paper
• Allosteric regulation of CAD modulates de novo pyrimidine synthesis during the cell cycle

  2023cites this paper
• EXSCALATE: An Extreme-Scale Virtual Screening Platform for Drug Discovery Targeting Polypharmacology to Fight SARS-CoV-2

  2023cites this paper
• Advances in the discovery of new chemotypes through ultra-large library docking

  2023cites this paper
• Properly Substituted Benzimidazoles as a New Promising Class of Nicotinate Phosphoribosyltransferase (NAPRT) Modulators

  2023cites this paper
• Computational approaches streamlining drug discovery

  2023cites this paper
• Recognizing the power of machine learning and other computational methods to accelerate progress in small molecule targeting of RNA

  2023cites this paper
• MetaDOCK: A Combinatorial Molecular Docking Approach

  2023cites this paper
• Pharmacological Characterization and Radiolabeling of VUF15485, a High-Affinity Small-Molecule Agonist for the Atypical Chemokine Receptor ACKR3

  2023cites this paper
• Delineating the behavior of Berberis anthocyanin/β-cyclodextrin inclusion complex in vitro: A molecular dynamics approach

  2022cites this paper
• Pesticide informatics expands the opportunity for structure-based molecular design and optimization

  2022cites this paper
• A Guide to In Silico Drug Design

  2022cites this paper
• Fluorescence turn off azastilbene sensor for detection of pesticides in vegetables: An experimental and computational investigation

  2022cites this paper
• A New 1,2,3-Triazole Scaffold with Improved Potency against Staphylococcus aureus Biotin Protein Ligase.

  2022cites this paper
• Combination of ligand and structure based virtual screening approaches for the discovery of potential PARP1 inhibitors

  2022cites this paper
• Novel Efficient Multistage Lead Optimization Pipeline Experimentally Validated for DYRK1B Selective Inhibitors

  2022cites this paper
• Impact of cancer-associated mutations in CC chemokine receptor 2 on receptor function and antagonism.

  2022cites this paper
• Allosteric Modulators of Dopamine D2 Receptors for Fine-Tuning of Dopaminergic Neurotransmission in CNS Diseases: Overview, Pharmacology, Structural Aspects and Synthesis

  2022cites this paper
• Synthesis and in silico evaluation of novel uridyl sulfamoylbenzoate derivatives as potential anticancer agents targeting M1 subunit of human ribonucleotide reductase (hRRM1)

  2022cites this paper
• Discovery of Triple Inhibitors of Both SARS-CoV-2 Proteases and Human Cathepsin L

  2022cites this paper
• Synergistic interactions of repurposed drugs that inhibit Nsp1, a major virulence factor for COVID-19

  2022cites this paper
• Chemometric Study, Homology Modeling of G Protein-Coupled Bile Acids Receptor (GPBAR_HUMAN) of Type-2 Diabetes Mellitus, Virtual Screening Evaluation, Drug-Likeness and ADME Prediction for Newly Designed Compounds

  2022cites this paper
• Discovery of MurA Inhibitors as Novel Antimicrobials through an Integrated Computational and Experimental Approach

  2022cites this paper
• Molecular modelling and in vitro studies of Daruharidra as a potent alpha-amylase inhibitor

  2022cites this paper
• C6 Hydroxymethyl-Substituted Carbapenem MA-1-206 Inhibits the Major Acinetobacter baumannii Carbapenemase OXA-23 by Impeding Deacylation

  2022cites this paper